Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wang Baochi Pill versus mosapride for functional dyspepsia
ChiCTR1900026288Phase 4Recruiting
- Sponsor
- Changhai Hospital
- Start
- Sep 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Wangshi Baochi Wan in functional dyspepsia (FD) (2 arms), sponsored by Changhai Hospital. Primary endpoint: Improvement rate of main symptoms. Started Sep 2019; status: recruiting.
02
Drugs
Wangshi Baochi Wan
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR1900026288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026288.